Signposts to Chiral Drugs

1. Organic Synthesis in Drug Discovery and Development
Vitomir Šunjić, Michael J. Parnham

2. Aliskiren Fumarate
Vitomir Šunjić, Michael J. Parnham

3. (R)-K-13675
Vitomir Šunjić, Michael J. Parnham

4. Sitagliptin Phosphate Monohydrate
Vitomir Šunjić, Michael J. Parnham

5. Biaryl Units in Valsartan and Vancomycin
Vitomir Šunjić, Michael J. Parnham

6. 3-Amino-1,4-Benzodiazepines
Vitomir Šunjić, Michael J. Parnham

7. Sertraline
Vitomir Šunjić, Michael J. Parnham

8. 1,2-Dihydroquinolines
Vitomir Šunjić, Michael J. Parnham

9. (−)-Menthol
Vitomir Šunjić, Michael J. Parnham

10. Fexofenadine Hydrochloride
Vitomir Šunjić, Michael J. Parnham

11. Montelukast Sodium
Vitomir Šunjić, Michael J. Parnham

12. Thiolactone Peptides as Antibacterial Peptidomimetics
Vitomir Šunjić, Michael J. Parnham

13. Efavirenz
Vitomir Šunjić, Michael J. Parnham

14. Paclitaxel
Vitomir Šunjić, Michael J. Parnham

15. Neoglycoconjugate
Vitomir Šunjić, Michael J. Parnham

16. 12-Aza-Epothilones
Vitomir Šunjić, Michael J. Parnham

Avainsanat: Biomedicine, Pharmacology/Toxicology, Pharmaceutical Sciences/Technology, Organic Chemistry, Medicinal Chemistry, Medical Biochemistry, Industrial Chemistry/Chemical Engineering